¿Qué relación existe entre la otitis y el colesteatoma?
colestheatoma otitis
Summary
Cholesteatoma in the context of otitis media is a benign, keratinizing epithelial lesion in the middle ear or mastoid, often acquired due to chronic suppurative otitis media (CSOM), leading to bone erosion, hearing loss, and potential complications. It requires surgical excision as primary treatment, with imaging (HRCT/MRI) aiding diagnosis; prevalence is approximately 10 per 100,000, higher in CSOM cases.[1][2][3]
Definition and Classification
Cholesteatoma is defined as the presence of keratinizing squamous epithelium in the middle ear or mastoid space, forming a cystic structure filled with keratin debris over a fibrous stroma.[3][1][4] It is not neoplastic or cholesterol-containing.[1]
- Acquired: Most common, linked to Eustachian tube dysfunction, chronic otitis media, retractions, or perforations (e.g., atticoantral type).[1][5][6]
- Congenital: Rare, epithelial inclusion behind intact tympanic membrane without otitis history; often asymptomatic initially.[7][5][8]
- Subtypes: Primary (pars flaccida), secondary (migration via perforation), external auditory canal (rare).[3][9]
EAONO/JOS consensus classifies by location, extent, and staging for surgical outcomes.[10]
Epidemiology and Prevalence
Incidence of acquired cholesteatoma is 9.2-10 per 100,000 annually.[1][5] In CSOM cohorts, 30% may have cholesteatoma, with 45% pediatric cases and male predominance (70%).[3][11] Peaks at 5-15 years; overlaps with otitis media incidence, delaying diagnosis.[12] Higher in chronic ear disease; Brazilian study: 419 cases showed hypoacusis/otorrhea as typical.[11]
Clinical Presentation and Risk Factors
Common: Foul-smelling otorrhea, hearing loss, ear fullness; complications include ossicular destruction, facial palsy, vertigo, labyrinthine/intracranial issues (e.g., abscess, meningitis).[1][13][14] Risk factors: Chronic otitis media, Eustachian dysfunction, repeated infections, possibly genetic variants or coagulation changes.[15][16][17] TLR4 promotes inflammation/bone destruction.[5] Pediatric cases more aggressive.[12]
Diagnosis
- Clinical: Otoscopy shows white mass, retraction pockets, perforations; persistent otorrhea raises suspicion.[1][6]
- Imaging: HRCT defines bony erosion (sensitivity 83.3%, specificity 58.3%); DWI-MRI superior for soft tissue (sensitivity/specificity 91.6%).[2][18] Correlate with intraoperative findings.
- Histopathology: Stratified squamous epithelium, keratin debris, inflammation.[3][19]
- Microbiology: Pseudomonas aeruginosa (31%), S. aureus (19%); superinfection drives aggression.[20][21]
No vital signs provided; if available, restate exactly for analysis.
Scientific Evidence
- HRCT/MRI study (n=40): MRI outperforms HRCT in cholesteatoma detection.[2]
- Pathogenesis: Hyperproliferation, EMT via osteopontin/HIF-1α; TLR4-mediated osteoclastogenesis.[5][22][23]
- Staging: EAONO/JOS for severity/removal difficulty.[10]
- Recurrence: 10-20% post-surgery; linked to incomplete excision.[24]
Treatment and Clinical Decision-Making
Surgical excision is definitive; medical therapy ineffective.[1][25]
| Approach | Indications | Outcomes |
|---|---|---|
| Canal Wall Up (CWU) | Limited disease, good mastoid aeration | Hearing preservation; higher recurrence risk. |
| Canal Wall Down (CWDT) | Extensive cholesteatoma, poor aeration | Lower recurrence; poorer hearing.[26] |
| Endoscopic | Congenital/early; transcanal | Excellent for pediatric; reduced morbidity.[27][25] |
- Guidelines: Timely surgery per EAONO/JOS staging; mastoidectomy ± ossiculoplasty.[10][24]
- Decisions: Stage via CT/MRI; CWDT for complications; second-look for CWU.[26]
- Novel: Mucosal regeneration via cell sheets post-resection.[28]
Patient Safety and Risks
- Complications: Recurrence (matrix remnants), iatrogenic hearing loss, facial nerve injury, CSF leak.[24][14]
- Side Effects: Postoperative otorrhea, vertigo; monitor with audiometry, imaging.
- Monitoring: Regular otoscopy, audiograms; antibiotics for infection (e.g., vs. Pseudomonas).[20]
- Contraindindications: Active intracranial infection (stabilize first).[13][29]
- Variability: Pediatrics more aggressive; genetic/microbiome factors affect response.[3][21][16]
Health Impact
Untreated: Irreversible deafness (77% moderate), ossicular/facial damage, intracranial spread (abscess mortality risk).[30][13] Surgery restores function in most; long-term: 70-90% hearing gain possible.[26]
Fuentes
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11464026/
- http://www.radiologypaper.com/archives/2019.v2.i2.B.77
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9441961/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9731553/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4671024/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8680935/
- https://www.semanticscholar.org/paper/e62d7acee8394ae932764cdfb3771b54eb136c9c
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9449072/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1769393/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6081285/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9442758/
- https://journal.nds.ox.ac.uk/index.php/JNDS/article/download/152/73
- https://www.cambridge.org/core/product/identifier/S0022215116005077/type/journal_article
- https://rjor.ro/diagnosis-and-therapeutic-management-of-complicated-middle-ear-cholesteatoma-a-narrative-review/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1069039/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9868167/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9884986/
- http://link.springer.com/10.1007/s00405-011-1577-z
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9445956/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2816367/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11822790/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10960243/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11135870/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11594670/
- https://www.semanticscholar.org/paper/5c1ec370b6f738688c3b5d7edb8779f8415f8a5e
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9411471/
- http://juniperpublishers.com/gjo/pdf/GJO.MS.ID.556049.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5665617/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9561596/
- https://www.banglajol.info/index.php/MEDISCOPE/article/download/34999/23595
- https://www.semanticscholar.org/paper/6b74f60c172e57d3ac5e739ee5db7c1271d9e8c5
- https://www.semanticscholar.org/paper/c14f52b1da42d3e42006edde0e22d29d99eb5e6a
- https://www.semanticscholar.org/paper/e9d6e041e8803b4658596d00735e9f1b9debd038
- https://www.bmj.com/lookup/doi/10.1136/bmj.325.7373.1159
- https://www.semanticscholar.org/paper/4979cc56082e942a9d30f6610151b5769d56b35d
- https://www.cureus.com/articles/116977-diagnosis-and-treatment-modalities-of-cholesteatomas-a-review.pdf
- https://www.mdpi.com/2077-0383/13/22/6791/pdf?version=1731391356
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3095160/
- https://publications.goettingen-research-online.de/bitstream/2/91926/1/2161-119X-S5-001.pdf
- http://juniperpublishers.com/gjo/pdf/GJO.MS.ID.555998.pdf
- https://journals.lww.com/10.1097/MD.0000000000037511
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5408875/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5205518/
- https://www.clinical-medicine.panafrican-med-journal.com/content/article/1/11/full/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7837648/
- https://www.genesispub.org/resource/images/articles/pdf258.pdf
- https://www.banglajol.info/index.php/BJO/article/download/53214/37574
- http://downloads.hindawi.com/journals/criot/2013/865043.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10474165/
- http://medicaljournal.gazi.edu.tr/index.php/GMJ/article/view/2875
Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.